New PBM contracting entities, often categorized as group purchasing organizations, add another obstacle to industry transparency
Cigna restricts coverage for Amylyx Pharmaceutical’s ALS drug Relyvrio due to the lack of clinical efficacy data and unclear clinical benefit
AMI’s new report, Primary Care Providers: Evolving in 2023-2024 provides a background of the primary care market and profiles the companies that will be leading the market in 2023 and beyond
As a result of a dispute with Express Scripts, Kroger and Prime Therapeutics announced a direct agreement for the Kroger Family of Pharmacies to remain in-network
AMI has recently published BusIntell Reports on 10 of the leading companies transforming the healthcare market.
Cigna recently launched Cigna Pathwell Specialty to offer access to a specialty pharmacy network for infusion and infection drugs, which is designed to be national and cost-effective
Centene recently announced that it reached its pharmacy platform migration milestones and is engaged in strategic discussions with potential PBM partners about how to drive additional quality and value in delivering pharmacy benefits to its members.
In the area of specialty pharmacy services, the Kaiser-Evernorth agreement seeks to deliver overall value and savings to Kaiser Permanente and its commercial plan members